Skip to content

    Niva Bupa Health

    NIVABUPA
    Financial Services·8 May 2026
    Management Summary

    Niva Bupa Health reported strong financial results for Q4 and full year FY26, driven by robust GWP growth, significant PAT increase, and improved operational efficiency. The company saw its combined ratio improve and expense ratio decline, while also gaining retail health market share. Management highlighted strategic investments in distribution, technology, and healthcare initiatives to sustain growth and profitability.

    Highlights

    8

    • Overall GWP grew 27.4% to INR 9,433 crores for FY26, with retail growth at 35% for the full year.

    • Profit After Tax (Ind AS) increased 80% YoY to INR 366 crores for FY26, with Q4 PAT up 90%.

    • Return on Net Worth (ROE) crossed double digit to 10.7%.

    • Combined Ratio (IFRS) improved by 160 bps to 101.4% for FY26.

    • Expense of Management Ratio improved to 33.7% from 39.2% last year, driven by operating leverage and economies of scale.

    • Retail health market share closed at 10.1% for FY26, up from 9.4%, and reached 10.4% in Q4 FY26.

    • Solvency ratio stood at a healthy 2.49 as on March 31, 2026.

    • Volume growth for the organization was 24%, with average ticket size growing 14-14.5% in H2 FY26.

    Concerns

    2

    • Overall loss ratio increased by 1.1% primarily due to mix change.

    • AUM growth seems to have slowed down in FY26 versus the prior 2 years, though management attributed this to capital raising rather than business slowdown.

    Key financials

    Metrics

    12

    Periods

    3

    Headline

    10
    • Overall GWP
      ₹9,433 Cr
      YoY+27.4%
    • Retail Growth
      —
      YoY+35%
    • PAT (Ind AS)
      ₹366 Cr
      YoY+80%
    • ROE
      10.7%
    • Combined Ratio (IFRS)
      101.4%

    Q4 FY26

    1
    • Retail Health Market Share
      10.4%

    FY26

    1
    • Retail Health Market Share
      10.1%

    Guidance & targets

    3
    CategoryTargetPriority
    Profitability
    Combined Operating Ratio (IFRS)
    99%
    		High
    Market Growth
    Retail Health Industry Growth Rate
    17-19% CAGR
    		High
    Other
    Common Empanelment Initiative - Hospitals
    5,000 hospitals
    		High

    Progress on common empanelment initiative

    next 4-5 months
    Current2,500 hospitals empanelled
    Target5,000 hospitals

    Why it matters

    Expansion of preferred provider network improves access, standardizes care, and helps manage claims costs, impacting overall profitability.

    And the idea is to get to maybe 5,000 in the next 4, 5 months.

    How to verify

    guidance_and_targets[category='Other', metric='Common Empanelment Initiative - Hospitals']

    Risks & concerns

    1
    RiskSeverity

    Potential commission caps/reductions due to regulatory changes

    Management awaits guidance from authority but believes in single limit on expense of management and is confident that volume growth from affordability will compensate for any impact. — Analyst acknowledged

    medium

    Q&A highlights

    8

    “One of our sources of strength, we feel as a management team and it's a strategic choice is our multichannel distribution architecture. Last year, as you would have seen, we've considerably increased our distribution spread, net addition of 58,000 agents, addition of 50-plus brokers, I think 23 additional financial institutions that are now part of our distribution strength.”

    Provides insight into the company's strategy for achieving ambitious growth targets, focusing on distribution expansion and product diversification.

    asked by Supratim Datta (Jefferies)

    2 min read7 chapters

    Detailed Narrative

    01

    Strong Financial Performance in FY26

    Niva Bupa Health reported a robust FY26, with overall Gross Written Premium (GWP) growing by 27.4% to INR 9,433 crores. Retail growth was particularly strong at 35% for the full year. Profit After Tax (PAT) on an Ind AS basis surged by 80% year-on-year to INR 366 crores, with Q4 PAT increasing by 90%. The company's Return on Net Worth (ROE) reached a double-digit 10.7%.

    02

    Improved Operational Efficiency

    The combined ratio under IFRS improved by 160 basis points to 101.4% for FY26, despite a 1.1% increase in the overall loss ratio due to mix changes. This improvement was primarily driven by a significant reduction in the expense of management ratio, which improved to 33.7% from 39.2% in the previous year, reflecting operating leverage and economies of scale. The company comfortably complied with the regulatory prescribed EOM limit.

    03

    Growing Market Share and Distribution

    Niva Bupa's retail health market share increased to 10.1% for the full year, up from 9.4%, and further to 10.4% in Q4. The company expanded its distribution network significantly, adding 58,000 agents, over 50 brokers, and 23 financial institutions. Volume growth for the organization stood at 24%, complemented by a 14-14.5% increase in average ticket size in H2 FY26, partly driven by GST benefits.

    04

    Industry Developments and Regulatory Landscape

    Management highlighted positive industry developments, including the successful 'Achha Kiya Insurance Liya' awareness campaign and the positive tailwind from GST, which contributed to 30% retail health growth for the industry in H2. The notification of IFRS 17 (Ind AS) effective April 2026 was also noted as a positive for transparency. The company has been reporting under IFRS and will go live this quarter.

    05

    Claims Management and Healthcare Initiatives

    The company maintained a strong claims settlement rate of over 94% for the full year. Initiatives around hospitals and collaboration continue, with the common empanelment initiative reaching 2,500 hospitals (excluding top 20 groups) and targeting 5,000 in the next 4-5 months. Standard treatment protocols for 7 infections are live, aiming to bring transparency and improve affordability.

    06

    Talent and Customer Focus

    Niva Bupa was recertified as a Great Place to Work and continues to rank among the top 25 in banking and financial services. Customer satisfaction, measured by NPS across 25 touchpoints, improved to 60 from 55 in the prior year. The company is also investing in analytics, generative AI, and technology, with over 30 pilots underway to enhance the value chain and bend the cost curve.

    07

    Long-Term Outlook and Strategy

    The company aims for a combined operating ratio of around 99% by FY29 under IFRS, with loss ratio remaining stable or slightly increasing and expense ratio contributing to savings. Management expects the retail health industry to grow at a 17-19% CAGR over a 5-year view. The strategy for growth involves continued investment in multi-channel distribution, tapping into newer customer segments, and expanding its Bharat strategy.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.